Regulatory

Jun 03, 2016
California is in the process of potentially establishing a new, disruptive healthcare policy that is proving to be very concerning to the American Rx industry, writes Tom Norton.
Jun 01, 2016
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
Jun 01, 2016
NHS England head Simon Stevens believes the UK's PPRS needs significantly updating.
May 25, 2016
We desperately need new anti-infective drugs to avoid life threatening infections. Let’s make that happen by punishing companies who don’t invest in R&D for these specific drugs.
May 24, 2016
Is a more "light-touch" appraisal process the key to getting the UK's NICE to do more with less? Leela Barham reports.
May 12, 2016
Election-year activities may stall the passage of biomedical innovation bill in 2016.
May 04, 2016
The dilemma continues: Which medicines should Europe's health systems pay for – and how much should they pay?
Apr 27, 2016
Pharmaceutical Executive
Policymakers seek to limit prescribing while also encouraging innovative R&D.
Mar 21, 2016
NICE's notion to charge the industry for its technology appraisals looks set to become reality, writes Leela Barham.
Mar 11, 2016
Doctors and oncologists agree with pharma companies in opposing the latest proposal from the CMS to revise how it pays for drugs administered in doctors’ offices.
native1_300x100
lorem ipsum